Protagonist Therapeutics (PTGX) PT Lowered to $45 at BTIG
Tweet Send to a Friend
BTIG analyst Julian Harrison lowered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
